Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Glickman
Dr. Michael Glickman is an infectious disease specialist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 33 years. He is one of 33 doctors at Memorial Sloan Kettering Cancer Center who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1996 - 2000
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
Columbia University Vagelos College of Physicians and SurgeonsClass of 1993
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 1996 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
- Elected Member The American Society for Clinical Investigation, 2007
Publications & Presentations
PubMed
- 11 citationsA fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via reprogramming granulopoiesis.Leonardo F Jurado, Andrew W Daman, Ziyi Li, Vanessa M S Ross, Kristina Nikolaou
Immunity. 2025-08-12 - 18 citationsMicrobial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity.Andrew W Daman, Anthony C Antonelli, Gil Redelman-Sidi, Lucinda Paddock, Shireen Khayat
Cancer Cell. 2025-08-11 - Waste as an antibacterial weapon.M Maria Elgrail, Michael S Glickman
Cell Host & Microbe. 2025-07-09
Journal Articles
- Challenges for the MD Physician-Scientist Upon Entering the Lab: From the Grand to the PracticalMichael Glickman, MD, The Journal of Infectious Diseases
Press Mentions
New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More BroadlyMay 29th, 2025- BCG Immunotherapy Reprograms Bone Marrow to Boost Cancer DefenseMay 28th, 2025
- New Insights into Decades-Old Bladder Cancer Treatment Offers Clues for ImmunotherapyMay 28th, 2025
Grant Support
- Chalkophore mediated respiratory oxidase flexibility and M. tuberculosis virulenceSLOAN-KETTERING INST CAN RESEARCH2026–2029
- Determinants of TB control, relapse and reinfectionWEILL MEDICAL COLL OF CORNELL UNIV2025–2026
- Mycobacterial DNA repair and mutagenesisSLOAN-KETTERING INST CAN RESEARCH2005–2025
- CD4 T Cell Responses To M. Tuberculosis InfectionNational Institute Of Allergy And Infectious Diseases2009–2011
- Cyclopropane Synthetases And M.Tuberculosis PathogenesisNational Institute Of Allergy And Infectious Diseases2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
